ReviewPathogens (Basel, Switzerland)2026
Loop-Mediated Isothermal Amplification (LAMP) for the Diagnosis of High-Burden Viral Diseases in Resource-Limited Countries.
Review in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Capillary-Driven Microfluidic Electrical Screening of Influenza H3N2-Infected A549 Cells Using AgNP-Decorated Laser-Patterned Villous Microstructures.Biosensors · 2026Article
- Detection of Dengue Virus Serotype 3 Using a Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification Assay: Evaluation with Clinical Samples from Southeastern Mexico.Pathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Loop-mediated isothermal amplification (LAMP) is an innovative nucleic acid amplification technique that operates under isothermal conditions and is distinguished by its high analytical efficiency, cost-effectiveness, and operational simplicity. Unlike conventional molecular assays, LAMP does not require sophisticated instrumentation or highly specialized personnel, rendering it particularly suitable for diagnostic deployment in resource-limited settings. Reaction outcomes are typically determined through direct visual inspection, often via colorimetric readouts, further enhancing its applicability in decentralized and point-of-care contexts. Owing to these attributes, LAMP has emerged as a valuable tool for the diagnosis of infectious diseases, particularly in regions with constrained laboratory infrastructure. Its affordability, rapid turnaround time, and ease of implementation support large-scale testing during public health emergencies, including epidemics and outbreaks, thereby contributing to the reduction in disease burden. Timely and accurate pathogen detection using LAMP can substantially strengthen public health responses aimed at controlling and mitigating viral transmission. This review provides an overview of the LAMP methodology, with an emphasis on its application in the detection of viral pathogens with epidemic and pandemic potential. Dengue virus and influenza virus are discussed as representative model infections to illustrate the diagnostic performance and practical advantages of LAMP-based assays. In addition, we explore current challenges and future perspectives for the implementation of LAMP in resource-limited settings, highlighting the need for continued technological refinement and contextual adaptation to maximize its impact on global health initiatives.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.